Elsevier, in cooperation with some pharmaceutical companies, published over 5 journal-like entitities from 2000-2008. These "journals" were given names that sounded basically reputable, but were essentially reprints of works that appeared in other Elsevier journals and featured works that touted the benefits of drugs produced by these drug companies.
THE world's largest medical publisher asked the manufacturers of anti-inflammatory drug Vioxx which articles they wanted to include in a so-called medical journal on bone health.